AU7067594A - A stabilised phenylalanine ammonia lyase - Google Patents

A stabilised phenylalanine ammonia lyase

Info

Publication number
AU7067594A
AU7067594A AU70675/94A AU7067594A AU7067594A AU 7067594 A AU7067594 A AU 7067594A AU 70675/94 A AU70675/94 A AU 70675/94A AU 7067594 A AU7067594 A AU 7067594A AU 7067594 A AU7067594 A AU 7067594A
Authority
AU
Australia
Prior art keywords
ammonia lyase
phenylalanine ammonia
pct
stabilised
sec
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU70675/94A
Other languages
English (en)
Inventor
Ib Groth Clausen
Peter Eigtved
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of AU7067594A publication Critical patent/AU7067594A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Detergent Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Lubricants (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU70675/94A 1993-06-25 1994-06-09 A stabilised phenylalanine ammonia lyase Abandoned AU7067594A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK755/93 1993-06-25
DK93755A DK75593D0 (en:Method) 1993-06-25 1993-06-25
PCT/DK1994/000224 WO1995000171A1 (en) 1993-06-25 1994-06-09 A stabilised phenylalanine ammonia lyase

Publications (1)

Publication Number Publication Date
AU7067594A true AU7067594A (en) 1995-01-17

Family

ID=8097168

Family Applications (1)

Application Number Title Priority Date Filing Date
AU70675/94A Abandoned AU7067594A (en) 1993-06-25 1994-06-09 A stabilised phenylalanine ammonia lyase

Country Status (10)

Country Link
US (1) US5753487A (en:Method)
EP (1) EP0703788B1 (en:Method)
AT (1) ATE209044T1 (en:Method)
AU (1) AU7067594A (en:Method)
CA (1) CA2165281A1 (en:Method)
DE (1) DE69429167T2 (en:Method)
DK (2) DK75593D0 (en:Method)
ES (1) ES2168297T3 (en:Method)
PT (1) PT703788E (en:Method)
WO (1) WO1995000171A1 (en:Method)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6051020A (en) 1994-02-09 2000-04-18 Boston Scientific Technology, Inc. Bifurcated endoluminal prosthesis
CA2233343A1 (en) 1995-09-29 1997-04-03 Ibex Technologies Inc. Use of heparinases to decrease inflammatory responses
US5647368A (en) * 1996-02-28 1997-07-15 Xillix Technologies Corp. Imaging system for detecting diseased tissue using native fluorsecence in the gastrointestinal and respiratory tract
US6190883B1 (en) 1998-09-09 2001-02-20 Novo Nordisk A/S Method for the production of heterologous polypeptides in transformed yeast cells
US6368837B1 (en) 1999-08-06 2002-04-09 E. I. Du Pont Nemours And Company Bioproduction of para-hydroxycinnamic acid
US6521748B2 (en) * 1999-08-06 2003-02-18 E. I. Du Pont De Nemours And Company Polynucleotide encoding a mutant Rhodotorula glutinis tyrosine ammonia lyase polypeptide
CA2442524A1 (en) * 2001-02-16 2002-09-12 Guiyi Zhang-Sun Matrix stabilized enzyme crystals and methods of use
JP2008513027A (ja) * 2004-09-17 2008-05-01 バイオマリン ファーマシューティカル インコーポレイテッド フェニルアラニンアンモニアーリアーゼの改変体および化学的に修飾された改変体
EP1869174B1 (en) 2005-03-10 2015-02-18 BASF Enzymes LLC Lyase enzymes, nucleic acids encoding them and methods for making and using them
US20070122344A1 (en) 2005-09-02 2007-05-31 University Of Rochester Medical Center Office Of Technology Transfer Intraoperative determination of nerve location
US7534595B2 (en) 2006-06-12 2009-05-19 Biomarin Pharmaceutical Inc. Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions thereof
US7531341B1 (en) 2006-06-12 2009-05-12 Biomarin Pharmaceutical Inc. Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions thereof
US20080161744A1 (en) 2006-09-07 2008-07-03 University Of Rochester Medical Center Pre-And Intra-Operative Localization of Penile Sentinel Nodes
US7560263B2 (en) * 2007-08-17 2009-07-14 Biomarin Pharmaceutical Inc. Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof
US8406860B2 (en) 2008-01-25 2013-03-26 Novadaq Technologies Inc. Method for evaluating blush in myocardial tissue
US10219742B2 (en) 2008-04-14 2019-03-05 Novadaq Technologies ULC Locating and analyzing perforator flaps for plastic and reconstructive surgery
EP3372250B1 (en) 2008-05-02 2019-12-25 Novadaq Technologies ULC Methods for production and use of substance-loaded erythrocytes for observation and treatment of microvascular hemodynamics
US9376659B2 (en) 2008-07-24 2016-06-28 Arch Personal Care Products, L.P. Personal care composition containing yeast/polyphenol ferment extract
WO2010014225A2 (en) * 2008-07-30 2010-02-04 Biomarin Pharmaceutical Inc. Assays for detection of phenylalanine ammonia-lyase and antibodies to phenylalanine ammonia-lyase
US10492671B2 (en) 2009-05-08 2019-12-03 Novadaq Technologies ULC Near infra red fluorescence imaging for visualization of blood vessels during endoscopic harvest
JP5828844B2 (ja) 2010-02-04 2015-12-09 ビオマリン プハルマセウトイカル インコーポレイテッド 原核生物フェニルアラニンアンモニアリアーゼ変異体の組成物、及び、その組成物を用いる方法
CA2803959C (en) 2010-06-30 2021-01-19 Codexis, Inc. Chemically modified carbonic anhydrases useful in carbon capture systems
WO2013190391A2 (en) 2012-06-21 2013-12-27 Novadaq Technologies Inc. Quantification and analysis of angiography and perfusion
US9611468B2 (en) * 2013-04-18 2017-04-04 Codexis, Inc. Engineered phenylalanine ammonia lyase polypeptides
AU2015327665B2 (en) 2014-09-29 2018-09-27 Stryker European Operations Limited Imaging a target fluorophore in a biological material in the presence of autofluorescence
US10631746B2 (en) 2014-10-09 2020-04-28 Novadaq Technologies ULC Quantification of absolute blood flow in tissue using fluorescence-mediated photoplethysmography
JP6931705B2 (ja) 2017-02-10 2021-09-08 ノバダック テクノロジーズ ユーエルシー オープンフィールドハンドヘルド蛍光イメージングシステムおよび方法
US10995329B2 (en) 2017-02-13 2021-05-04 Codexis, Inc. Engineered phenylalanine ammonia lyase polypeptides

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH538003A (fr) * 1968-03-29 1973-01-31 Anvar Procédé pour l'obtention d'articles textiles porteurs d'enzymes
IT1096208B (it) * 1978-05-12 1985-08-26 Snam Progetti Composizione adatta alla riduzione del tenore di fenilalanina e metodo impiegante la stessa
FR2523445A1 (fr) * 1982-03-17 1983-09-23 Sanofi Sa Nouveaux conjugues associant, par liaison covalente, une enzyme et un anticorps, et associations medicamenteuses utilisant lesdits conjugues

Also Published As

Publication number Publication date
PT703788E (pt) 2002-05-31
DK75593D0 (en:Method) 1993-06-25
US5753487A (en) 1998-05-19
DE69429167D1 (de) 2002-01-03
ATE209044T1 (de) 2001-12-15
WO1995000171A1 (en) 1995-01-05
CA2165281A1 (en) 1995-01-05
DE69429167T2 (de) 2002-07-04
ES2168297T3 (es) 2002-06-16
EP0703788B1 (en) 2001-11-21
EP0703788A1 (en) 1996-04-03
DK0703788T3 (da) 2002-05-21

Similar Documents

Publication Publication Date Title
AU7067594A (en) A stabilised phenylalanine ammonia lyase
FR05C0045I2 (en:Method)
TW279166B (en:Method)
TW326394B (en) Insulin formulation
MY119820A (en) Guanidine mimics as factor xa inhibitors
MX9601360A (es) Mezcla estabilizante sinergistica.
UA43348C2 (uk) Водна фармацевтична композиція, що включає фактор росту нерва (варіанти) та ліофілізований фармацевтичний склад
GR3026531T3 (en) Treatment for insulin dependent diabetes.
GR3022510T3 (en) Lyospheres comprising gonadotropin
DE69428280D1 (de) Verfahren zur herstellung von azetidinonen
AU8078394A (en) Amidino derivatives useful as nitric oxide synthase inhibitors
SE9101838D0 (sv) Novel peptides and their use
DK0804223T3 (da) Farmaceutiske præparater indeholdende hGH
CA2296560A1 (en) Amino acid derivatives useful to treat stroke
MY133666A (en) Enzymatic process for stereoselective preparation of therapeutic amides
MX9605280A (es) Estabilizacion de 3-isotiazolonas no halogenadas en sistemas agresivos.
MX9602836A (es) MEZCLA QUE CONTIENE UNO O VARIOS ALFA-AMINOACIDOS Y SUS DERIVADOS, O AMBOS, Y UNO O VARIOS CICLOPENTANO- beta-AMINOACIDOS Y SUS DERIVADOS, O AMBOS.
AU3524993A (en) Method of peptide synthesis and new synthesis intermediates
AU6700996A (en) Somatostatin-analogous cyclic peptides with inhibitory activity on growth hormone
AU6670596A (en) Remedies for anxiety neurosis
GR3024267T3 (en) Cytotoxic t-lymphocyte antigen as cysteine protease inhibitor.
UA39178C2 (uk) Спосіб мінімізації деградації активованого протеїну с (варіанти), фармацевтична композиція та водний розчин активованого протеїну с
WO1994022911A3 (en) A PROCESS AND INTERMEDIATE COMPOUNDS USEFUL FOR THE PREPARATION OF PLATELET GLYCOPROTEIN IIb/IIIa INHIBITORS CONTAINING Nα-METHYLARGININE
AU8107094A (en) Endothelin-converting enzyme
MY116275A (en) A pharmaceutical composition for treating dysmenorrhea and premature labor